Refractory Lymphoma
Showing 26 - 34 of 34
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Nivolumab)
Completed
- Advanced Lymphoma
- +5 more
- Nivolumab
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Mar 15, 2021
Lymphoma, B-Cell, Relapse/Recurrence, Refractory Lymphoma Trial in Shenzhen (dual target CAR-T cell therapy)
Unknown status
- Lymphoma, B-Cell
- +3 more
- dual target CAR-T cell therapy
-
Shenzhen, Guangdong, ChinaShenzhen University General hospital
Jan 23, 2021
Hematologic Malignancy, Refractory Lymphoma Trial in Boston (Radiotherapy)
Not yet recruiting
- Hematologic Malignancy
- Refractory Lymphoma
- Radiotherapy
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 19, 2021
Advanced Malignant Solid Tumor, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in
Completed
- Advanced Malignant Solid Neoplasm
- +24 more
- Oxidative Phosphorylation Inhibitor IACS-010759
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 23, 2020
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Dasatinib)
Withdrawn
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jul 17, 2020
Advanced Lymphoma, Refractory Lymphoma, Refractory Leukemia Trial in Vienna (Next generation functional drug screening,
Recruiting
- Advanced Lymphoma
- +4 more
- Next generation functional drug screening
- Comprehensive genomic profiling
-
Vienna, AustriaMedical University of Vienna
Jul 10, 2020
Non-Hodgkin's Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in Berkeley Heights (gallium nitrate)
Completed
- Non-Hodgkin's Lymphoma
- +4 more
- gallium nitrate
-
Berkeley Heights, New JerseyGenta
Feb 7, 2006